Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Virol
1989 Nov 01;6311:4744-55. doi: 10.1128/JVI.63.11.4744-4755.1989.
Show Gene links
Show Anatomy links
Antigenic properties and cellular localization of herpes simplex virus glycoprotein H synthesized in a mammalian cell expression system.
Gompels UA
,
Minson AC
.
Abstract
Herpes simplex virus type 1 glycoprotein H (HSV-1 gH) was synthesized in an inducible mammalian cell expression system, and its properties were examined. The gH coding sequence, together with the stable 5' untranslated leader sequence from xenopus beta-globin, was placed under control of the strong promoter from the human cytomegalovirus major immediate-early gene in an amplifiable plasmid which contains the simian virus 40 (SV40) virus origin for replication (ori). This expression vector was transfected into ts COS cells constitutively expressing a temperature-sensitive SV40 T antigen which allows utilization of the SV40 ori at permissive temperatures. The results of transient expression assays at the permissive temperature showed that HSV-1 gH could be synthesized in greater amounts than those produced by a high-multiplicity virus infection. The proteins produced were detected in Western blots (immunoblots) with a HSV-1 gH-specific polyclonal serum raised against a TrpE-gH fusion protein. The transfected gH had an apparent molecular weight of approximately 105,000, intermediate in size to those of the precursor (100,000) and fully processed forms (110,000) of HSV-1 gH from infections. Antigenicity was investigated by reactions with three virus-neutralizing monoclonal antibodies specific for conformational epitopes on gH. Only one of these monoclonal antibodies could immunoprecipitate the synthesized gH. However, equal recognition of the transfected gH was achieved by superinfection with virus. In addition, detectable amounts of gH were not expressed on the cell surface unless the cells were superinfected with virus. Studies with a temperature-sensitive mutant, ts1201, defective in encapsidation showed that the changes in antigenic structure and cell surface expression caused by superinfection with virus were not due simply to incorporation of gH into virions. These results suggest that gH requires additional virus gene products for cell surface localization and formation of an antigenic structure important for its function in mediating infectivity.
Ackermann,
Identification, properties, and gene location of a novel glycoprotein specified by herpes simplex virus 1.
1986, Pubmed
Ackermann,
Identification, properties, and gene location of a novel glycoprotein specified by herpes simplex virus 1.
1986,
Pubmed
Addison,
Characterisation of a herpes simplex virus type 1 mutant which has a temperature-sensitive defect in penetration of cells and assembly of capsids.
1984,
Pubmed
Arsenakis,
Construction and properties of a cell line constitutively expressing the herpes simplex virus glycoprotein B dependent on functional alpha 4 protein synthesis.
1986,
Pubmed
Arsenakis,
Regulation of glycoprotein D synthesis: does alpha 4, the major regulatory protein of herpes simplex virus 1, regulate late genes both positively and negatively?
1988,
Pubmed
Belshe,
Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection.
1988,
Pubmed
Birnboim,
A rapid alkaline extraction procedure for screening recombinant plasmid DNA.
1979,
Pubmed
Buckmaster,
The use of monoclonal antibodies to differentiate isolates of herpes simplex types 1 and 2 by neutralisation and reverse passive haemagglutination tests.
1984,
Pubmed
Buckmaster,
Characterisation and physical mapping of an HSV-1 glycoprotein of approximately 115 X 10(3) molecular weight.
1984,
Pubmed
Cai,
Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion.
1988,
Pubmed
Chen,
High-efficiency transformation of mammalian cells by plasmid DNA.
1987,
Pubmed
Cohen,
Expression of herpes simplex virus type 1 glycoprotein D deletion mutants in mammalian cells.
1988,
Pubmed
Cranage,
Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus.
1986,
Pubmed
Cranage,
Identification and expression of a human cytomegalovirus glycoprotein with homology to the Epstein-Barr virus BXLF2 product, varicella-zoster virus gpIII, and herpes simplex virus type 1 glycoprotein H.
1988,
Pubmed
Davison,
Genetic relations between varicella-zoster virus and Epstein-Barr virus.
1987,
Pubmed
Desai,
Excretion of non-infectious virus particles lacking glycoprotein H by a temperature-sensitive mutant of herpes simplex virus type 1: evidence that gH is essential for virion infectivity.
1988,
Pubmed
Fuller,
Specificities of monoclonal and polyclonal antibodies that inhibit adsorption of herpes simplex virus to cells and lack of inhibition by potent neutralizing antibodies.
1985,
Pubmed
Fuller,
Anti-glycoprotein D antibodies that permit adsorption but block infection by herpes simplex virus 1 prevent virion-cell fusion at the cell surface.
1987,
Pubmed
Gluzman,
SV40-transformed simian cells support the replication of early SV40 mutants.
1981,
Pubmed
Gompels,
The properties and sequence of glycoprotein H of herpes simplex virus type 1.
1986,
Pubmed
Gompels,
Conservation of gene organization in the lymphotropic herpesviruses herpesvirus Saimiri and Epstein-Barr virus.
1988,
Pubmed
Gompels,
Conservation of glycoprotein H (gH) in herpesviruses: nucleotide sequence of the gH gene from herpesvirus saimiri.
1988,
Pubmed
Hay,
The molecular basis of the specific anti-influenza action of amantadine.
1985,
Pubmed
Heine,
Proteins specified by herpes simplex virus. XII. The virion polypeptides of type 1 strains.
1974,
Pubmed
Heineman,
Identification of the Epstein-Barr virus gp85 gene.
1988,
Pubmed
Highlander,
Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration.
1987,
Pubmed
Holland,
Herpes simplex virus type 1 glycoprotein C-negative mutants exhibit multiple phenotypes, including secretion of truncated glycoproteins.
1984,
Pubmed
Isola,
Fine mapping of antigenic site II of herpes simplex virus glycoprotein D.
1989,
Pubmed
Johnson,
Intracellular transport of herpes simplex virus gD occurs more rapidly in uninfected cells than in infected cells.
1985,
Pubmed
Johnson,
Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI.
1988,
Pubmed
Johnson,
Herpes simplex viruses lacking glycoprotein D are unable to inhibit virus penetration: quantitative evidence for virus-specific cell surface receptors.
1988,
Pubmed
Johnson,
Herpes simplex virus glycoprotein D mediates interference with herpes simplex virus infection.
1989,
Pubmed
Johnson,
Identification of a novel herpes simplex virus type 1-induced glycoprotein which complexes with gE and binds immunoglobulin.
1987,
Pubmed
Keller,
Identification and sequence of the gene encoding gpIII, a major glycoprotein of varicella-zoster virus.
1987,
Pubmed
Krieg,
Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs.
1984,
Pubmed
,
Xenbase
Kunkel,
Rapid and efficient site-specific mutagenesis without phenotypic selection.
1985,
Pubmed
Laemmli,
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
1970,
Pubmed
Ligas,
A herpes simplex virus mutant in which glycoprotein D sequences are replaced by beta-galactosidase sequences binds to but is unable to penetrate into cells.
1988,
Pubmed
Longnecker,
Generation of an inverting herpes simplex virus 1 mutant lacking the L-S junction a sequences, an origin of DNA synthesis, and several genes including those specifying glycoprotein E and the alpha 47 gene.
1986,
Pubmed
Longnecker,
Clustering of genes dispensable for growth in culture in the S component of the HSV-1 genome.
1987,
Pubmed
Longnecker,
Identification of a herpes simplex virus 1 glycoprotein gene within a gene cluster dispensable for growth in cell culture.
1987,
Pubmed
Manservigi,
Constitutive expression in human cells of herpes simplex virus type 1 glycoprotein B gene cloned in an episomal eukaryotic vector.
1988,
Pubmed
McGeoch,
DNA sequence of the herpes simplex virus type 1 gene encoding glycoprotein gH, and identification of homologues in the genomes of varicella-zoster virus and Epstein-Barr virus.
1986,
Pubmed
McGeoch,
The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1.
1988,
Pubmed
Miller,
A monoclonal antibody to glycoprotein gp85 inhibits fusion but not attachment of Epstein-Barr virus.
1988,
Pubmed
Minson,
An analysis of the biological properties of monoclonal antibodies against glycoprotein D of herpes simplex virus and identification of amino acid substitutions that confer resistance to neutralization.
1986,
Pubmed
Muggeridge,
Antigenic analysis of a major neutralization site of herpes simplex virus glycoprotein D, using deletion mutants and monoclonal antibody-resistant mutants.
1988,
Pubmed
Muller,
Isolation of large T antigen-producing mouse cell lines capable of supporting replication of polyomavirus-plasmid recombinants.
1984,
Pubmed
Nelson,
Negative and positive regulation by a short segment in the 5'-flanking region of the human cytomegalovirus major immediate-early gene.
1987,
Pubmed
Noble,
Anti-gD monoclonal antibodies inhibit cell fusion induced by herpes simplex virus type 1.
1983,
Pubmed
Oba,
Induction of antibodies to the Epstein-Barr virus glycoprotein gp85 with a synthetic peptide corresponding to a sequence in the BXLF2 open reading frame.
1988,
Pubmed
Olofsson,
Altered kinetic properties of sialyl and galactosyl transferases associated with herpes simplex virus infection of GMK and BHK cells.
1980,
Pubmed
Pachl,
The human cytomegalovirus strain Towne glycoprotein H gene encodes glycoprotein p86.
1989,
Pubmed
Para,
Potent neutralizing activity associated with anti-glycoprotein D specificity among monoclonal antibodies selected for binding to herpes simplex virions.
1985,
Pubmed
Preston,
Identification and characterization of a herpes simplex virus gene product required for encapsidation of virus DNA.
1983,
Pubmed
Rasmussen,
Murine monoclonal antibody to a single protein neutralizes the infectivity of human cytomegalovirus.
1984,
Pubmed
Richman,
Identification of a new glycoprotein of herpes simplex virus type 1 and genetic mapping of the gene that codes for it.
1986,
Pubmed
Rio,
A mammalian host-vector system that regulates expression and amplification of transfected genes by temperature induction.
1985,
Pubmed
Seed,
An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2.
,
Pubmed
Seidel-Dugan,
C3b receptor activity on transfected cells expressing glycoprotein C of herpes simplex virus types 1 and 2.
1988,
Pubmed
Shelbourn,
Expression of oncogenic ras in human teratocarcinoma cells induces partial differentiation and permissiveness for human cytomegalovirus infection.
1989,
Pubmed
Showalter,
Monoclonal antibodies to herpes simplex virus type 1 proteins, including the immediate-early protein ICP 4.
1981,
Pubmed
Skehel,
A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody.
1984,
Pubmed
Stirzaker,
The signal peptide of the rotavirus glycoprotein VP7 is essential for its retention in the ER as an integral membrane protein.
1989,
Pubmed
Strnad,
Production and characterization of monoclonal antibodies against the Epstein-Barr virus membrane antigen.
1982,
Pubmed
Su,
Inducible expression of herpes simplex virus type 2 glycoprotein gene gG-2 in a mammalian cell line.
1988,
Pubmed
Vidal,
Addition of high-mannose sugars must precede disulfide bond formation for proper folding of Sendai virus glycoproteins.
1989,
Pubmed
Weller,
Genetic analysis of temperature-sensitive mutants of HSV-1: the combined use of complementation and physical mapping for cistron assignment.
1983,
Pubmed
Whealy,
A herpesvirus vector for expression of glycosylated membrane antigens: fusion proteins of pseudorabies virus gIII and human immunodeficiency virus type 1 envelope glycoproteins.
1988,
Pubmed
Wilcox,
The contribution of cysteine residues to antigenicity and extent of processing of herpes simplex virus type 1 glycoprotein D.
1988,
Pubmed
